HAYA Therapeutics Appoints Brian C. Thomas, Ph.D., as Chairperson of the Board of Directors
LAUSANNE, Switzerland and SAN DIEGO – Sept. 15, 2022 -- HAYA Therapeutics, SA, a company...
Search for Articles
Sep 16, 2022
Sep 20, 2022
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
MIAMI, Sept. 13, 2022 /PRNewswire/ -- RapidPulse, Inc., a privately-held medical device company developing a...
Aug 22, 2022
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision...
Jul 13, 2022
Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Jul 13, 2022
Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
May 5, 2022
XII Medical Completes $30 Million Series A Financing
UNION CITY, Calif., May 5, 2022 /PRNewswire/ -- XII Medical, Inc., a private health technology company,...